| Ident. | Authors (with country if any) | Title |
|---|
| 000014 (2020) |
Kimiyasu Shiraki [Japon] ; Tohru Daikoku [Japon] | Favipiravir, an anti-influenza drug against life-threatening RNA virus infections |
| 000015 (2020) |
Su Mon Kyaw Win [Birmanie] ; Reiko Saito [Birmanie, Japon] ; Nay Chi Win [Birmanie] ; Di Ja Lasham [Birmanie] ; Yadanar Kyaw [Birmanie] ; Nay Lin [Birmanie] ; Khin Nyo Thein [Birmanie] ; Irina Chon [Japon] ; Takashi Odagiri [Japon] ; Win Thein [Birmanie] ; Latt Latt Kyaw [Birmanie] ; Ommar Swe Tin [Birmanie] ; Akihiko Saitoh [Japon] ; Tsutomu Tamura [Japon] ; Chika Hirokawa [Japon] ; Yuko Uchida [Japon] ; Takehiko Saito [Japon] ; Shinji Watanabe [Japon] ; Takato Odagiri [Japon] ; Kazuhiro Kamata [Birmanie, Japon] ; Hidekazu Osada [Birmanie, Japon] ; Clyde Dapat [Japon] ; Hisami Watanabe [Birmanie, Japon] ; Htay Htay Tin [Birmanie] | Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017 |
| 000045 (2019) |
Lifen Han [République populaire de Chine] ; Cong Chen [République populaire de Chine] ; Xianlin Han [République populaire de Chine] ; Shujin Lin [République populaire de Chine] ; Xiulan Ao [République populaire de Chine] ; Xiao Han [République populaire de Chine] ; Jianmin Wang [République populaire de Chine] ; Hanhui Ye [République populaire de Chine] | Structural Insights for Anti-Influenza Vaccine Design |
| 000077 (2019) |
Julie L. Mcauley [Australie] ; Brad P. Gilbertson [Australie] ; Sanja Trifkovic [Australie, États-Unis] ; Lorena E. Brown [Australie] ; Jennifer L. Mckimm-Breschkin [Australie] | Influenza Virus Neuraminidase Structure and Functions |
| 000089 (2019) |
Jiantao Zhang [États-Unis] ; Yanmei Hu [États-Unis] ; Rami Musharrafieh [États-Unis] ; Hang Yin [États-Unis] ; Jun Wang [États-Unis] | Focusing on the influenza virus polymerase complex: recent progress in drug discovery and assay development |
| 000095 (2019) |
Jiun-Jie Shie [Taïwan] ; Jim-Min Fang [Taïwan] | Development of effective anti-influenza drugs: congeners and conjugates – a review |
| 000164 (2018) |
Paul Santner [Danemark] ; João Miguel Da Silva Martins [Danemark] ; Caroline Kampmeyer [Danemark] ; Rasmus Hartmann-Petersen [Danemark] ; Jonas S. Laursen [Danemark] ; Amelie Stein [Danemark] ; Christian A. Olsen [Danemark] ; Isaiah T. Arkin [Israël] ; Jakob R. Winther [Danemark] ; Martin Willemoës [Danemark] ; Kresten Lindorff-Larsen [Danemark] | Random Mutagenesis Analysis of the Influenza A M2 Proton Channel Reveals Novel Resistance Mutants. |
| 000193 (2018) |
Chun-Yeung Lo ; Olive Tin-Wai Li ; Wen-Ping Tang [République populaire de Chine] ; Chun Hu [République populaire de Chine] ; Guo Xin Wang [République populaire de Chine] ; Jacky Chi-Ki Ngo ; David Chi-Cheong Wan ; Leo Lit-Man Poon ; Pang-Chui Shaw | Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening |
| 000196 (2018) |
Irina V. Ilyina [Russie] ; Vladimir V. Zarubaev [Russie] ; Irina N. Lavrentieva [Russie] ; Anna A. Shtro [Russie] ; Iana L. Esaulkova [Russie] ; Dina V. Korchagina [Russie] ; Sophia S. Borisevich [Russie] ; Konstantin P. Volcho [Russie] ; Nariman F. Salakhutdinov [Russie] | Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses. |
| 000206 (2018) |
Lei Deng [États-Unis] ; Teena Mohan [États-Unis] ; Timothy Z. Chang [États-Unis] ; Gilbert X. Gonzalez [États-Unis] ; Ye Wang [États-Unis] ; Young-Man Kwon [États-Unis] ; Sang-Moo Kang [États-Unis] ; Richard W. Compans [États-Unis] ; Julie A. Champion [États-Unis] ; Bao-Zhong Wang [États-Unis] | Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses |
| 000225 (2018) |
Tsz-Fung Yip [Hong Kong] ; Aisha Sami Mohammed Selim [Hong Kong] ; Ida Lian [Singapour] ; Suki Man-Yan Lee [Hong Kong] | Advancements in Host-Based Interventions for Influenza Treatment |
| 000229 (2018) |
Paul Santner [Danemark] ; João Miguel Da Silva Martins [Danemark] ; Jonas S. Laursen [Danemark] ; Lars Behrendt [Danemark] ; Leise Riber [Danemark] ; Christian A. Olsen [Danemark] ; Isaiah T. Arkin [Israël] ; Jakob R. Winther [Danemark] ; Martin Willemoës [Danemark] ; Kresten Lindorff-Larsen [Danemark] | A Robust Proton Flux (pHlux) Assay for Studying the Function and Inhibition of the Influenza A M2 Proton Channel. |
| 000271 (2017) |
Christopher J. Vavricka [Japon] ; Chiaki Muto [Japon] ; Tomohisa Hasunuma [Japon] ; Yoshinobu Kimura [Japon] ; Michihiro Araki [Japon] ; Yan Wu [République populaire de Chine] ; George F. Gao [République populaire de Chine] ; Hiroshi Ohrui [Japon] ; Minoru Izumi [Japon] ; Hiromasa Kiyota [Japon] | Synthesis of Sulfo-Sialic Acid Analogues: Potent Neuraminidase Inhibitors in Regards to Anomeric Functionality |
| 000311 (2017) |
Gwladys C. Monamele [Cameroun] ; Marie-Astrid Vernet [Cameroun] ; Mohammed R. Njankouo [Cameroun] ; Kathleen Victoir [France] ; Jane Francis Akoachere [Cameroun] ; Damian Anong [Cameroun] ; Richard Njouom [Cameroun] | Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons |
| 000328 (2017) |
Mazhar Hussain [Nouvelle-Zélande] ; Henry D. Galvin [Nouvelle-Zélande] ; Tatt Y. Haw [Nouvelle-Zélande] ; Ashley N. Nutsford [Nouvelle-Zélande] ; Matloob Husain [Nouvelle-Zélande] | Drug resistance in influenza A virus: the epidemiology and management |
| 000336 (2017) |
Naoki Takizawa ; Manabu Yamasaki | Current landscape and future prospects of antiviral drugs derived from microbial products |
| 000340 (2017) |
Guanying Hu [République populaire de Chine] ; Cheng Peng [République populaire de Chine] ; Xiaofang Xie [République populaire de Chine] ; Sanyin Zhang [République populaire de Chine] ; Xiaoyu Cao [République populaire de Chine] | Availability, Pharmaceutics, Security, Pharmacokinetics, and Pharmacological Activities of Patchouli Alcohol |
| 000408 (2016) |
Anna Gillman [Suède] | Risk of resistant avian influenza A virus in wild waterfowl as a result of environmental release of oseltamivir |
| 000416 (2016) |
Pengfei Wei [République populaire de Chine] ; Zelang Cai [République populaire de Chine] ; Jinwen Hua [République populaire de Chine] ; Weijia Yu [République populaire de Chine] ; Jiajie Chen [République populaire de Chine] ; Kang Kang [République populaire de Chine] ; Congling Qiu [République populaire de Chine] ; Lanlan Ye [République populaire de Chine] ; Jiayun Hu [République populaire de Chine] ; Kunmei Ji [République populaire de Chine] | Pains and Gains from China's Experiences with Emerging Epidemics: From SARS to H7N9 |
| 000433 (2016) |
Ergin Çiftçi [Turquie] ; Adem Karbuz [Turquie] ; Tan L Kendirli [Turquie] | Influenza and the use of oseltamivir in children |
| 000444 (2016) |
Wenshuai Wang [République populaire de Chine] ; Xiaoyu Sun [République populaire de Chine] ; Yanbing Li [République populaire de Chine] ; Jinpeng Su [République populaire de Chine] ; Zhiyang Ling [République populaire de Chine] ; Tianlong Zhang [République populaire de Chine] ; Fang Wang [République populaire de Chine] ; Hong Zhang [République populaire de Chine] ; Hualan Chen [République populaire de Chine] ; Jianping Ding [République populaire de Chine] ; Bing Sun [République populaire de Chine] | Human antibody 3E1 targets the HA stem region of H1N1 and H5N6 influenza A viruses |
